The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
AIM2 protein affects the reaction [artenimol results in increased expression of DFNA5 protein alternative form]; AIM2 protein affects the reaction [artenimol results in increased expression of DFNA5 protein]; AIM2 protein affects the reaction [artenimol results in increased expression of HMGB1 protein]; AIM2 protein affects the reaction [artenimol results in increased secretion of IL18 protein]; AIM2 protein affects the reaction [artenimol results in increased secretion of IL1B protein] artenimol results in increased expression of AIM2 mRNA; artenimol results in increased expression of AIM2 protein AIM2 protein affects the susceptibility to artenimol
artenimol results in increased cleavage of CASP3 protein acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [artenimol results in increased cleavage of CASP3 protein]; artenimol results in increased expression of and results in increased cleavage of CASP3 protein; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [artenimol results in increased cleavage of CASP3 protein]; GSDME protein affects the reaction [artenimol results in increased cleavage of CASP3 protein]; PKM protein inhibits the reaction [artenimol results in increased cleavage of CASP3 protein] artenimol results in increased expression of CASP3 mRNA
[artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in decreased expression of CPT1A mRNA]; [artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in decreased expression of CPT1A protein]; artenimol inhibits the reaction [Ethanol results in decreased expression of CPT1A mRNA]; artenimol inhibits the reaction [Ethanol results in decreased expression of CPT1A protein] Dihydroartemisinin inhibits the reaction [ethanol decreases expression of CPT1a mRNA and protein in liver]
[artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in increased expression of FASN mRNA]; [artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in increased expression of FASN protein]; artenimol inhibits the reaction [Ethanol results in increased expression of FASN mRNA]; artenimol inhibits the reaction [Ethanol results in increased expression of FASN protein]
artenimol inhibits the reaction [Ethanol results in increased activity of GPT protein]; artenimol promotes the reaction [NR1H4 protein inhibits the reaction [Ethanol results in increased activity of GPT protein]]; NR1H4 protein promotes the reaction [artenimol inhibits the reaction [Ethanol results in increased activity of GPT protein]]
DFNA5 protein affects the susceptibility to artenimol acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [artenimol results in increased cleavage of GSDME protein]; AIM2 protein affects the reaction [artenimol results in increased expression of DFNA5 protein alternative form]; AIM2 protein affects the reaction [artenimol results in increased expression of DFNA5 protein]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [artenimol results in increased cleavage of GSDME protein]; DFNA5 protein affects the reaction [artenimol results in increased expression of HMGB1 protein]; DFNA5 protein affects the reaction [artenimol results in increased secretion of IL18 protein]; DFNA5 protein affects the reaction [artenimol results in increased secretion of IL1B protein]; GSDME protein affects the reaction [artenimol results in increased cleavage of CASP3 protein]; GSDME protein affects the reaction [artenimol results in increased expression of IL1B protein]; GSDME protein affects the reaction [artenimol results in increased secretion of IL18 protein]; GSDME protein affects the reaction [artenimol results in increased secretion of IL1B protein]; PKM protein inhibits the reaction [artenimol results in increased cleavage of GSDME protein] artenimol results in increased expression of DFNA5 mRNA; artenimol results in increased expression of DFNA5 protein; artenimol results in increased expression of DFNA5 protein alternative form
artenimol results in increased expression of HMGB1 mRNA; artenimol results in increased expression of HMGB1 protein AIM2 protein affects the reaction [artenimol results in increased expression of HMGB1 protein]; DFNA5 protein affects the reaction [artenimol results in increased expression of HMGB1 protein]
acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [artenimol results in increased secretion of IL18 protein]; AIM2 protein affects the reaction [artenimol results in increased secretion of IL18 protein]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [artenimol results in increased secretion of IL18 protein]; DFNA5 protein affects the reaction [artenimol results in increased secretion of IL18 protein]; GSDME protein affects the reaction [artenimol results in increased secretion of IL18 protein]; PKM protein inhibits the reaction [artenimol results in increased secretion of IL18 protein] artenimol results in increased expression of IL18 mRNA; artenimol results in increased expression of IL18 protein
artenimol results in increased secretion of IL1B protein artenimol results in increased expression of IL1B mRNA; artenimol results in increased expression of IL1B protein acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [artenimol results in increased secretion of IL1B protein]; AIM2 protein affects the reaction [artenimol results in increased secretion of IL1B protein]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [artenimol results in increased secretion of IL1B protein]; DFNA5 protein affects the reaction [artenimol results in increased secretion of IL1B protein]; GSDME protein affects the reaction [artenimol results in increased expression of IL1B protein]; GSDME protein affects the reaction [artenimol results in increased secretion of IL1B protein]; PKM protein inhibits the reaction [artenimol results in increased expression of IL1B protein]; PKM protein inhibits the reaction [artenimol results in increased secretion of IL1B protein]
artenimol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK1 protein]; artenimol inhibits the reaction [TP53 protein mutant form results in increased phosphorylation of MAPK1 protein]
artenimol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of MAPK3 protein]; artenimol inhibits the reaction [TP53 protein mutant form results in increased phosphorylation of MAPK3 protein]
artenimol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP14 mRNA]; artenimol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP14 protein]
artenimol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP2 protein]; artenimol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP2 mRNA]
artenimol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of MMP9 protein]; artenimol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MMP9 mRNA]; artenimol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of MMP9 protein]
artenimol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased degradation of NFKBIA protein] Dihydroartemisinin inhibits the reaction [ethanol decreases expression of Nfkbia protein in liver]
[artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in decreased expression of CPT1A mRNA]; [artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in decreased expression of CPT1A protein]; [artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in decreased expression of NR1H4 mRNA]; [artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in decreased expression of NR1H4 protein]; [artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in decreased expression of PPARA mRNA]; [artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in decreased expression of PPARA protein]; [artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in increased expression of FASN mRNA]; [artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in increased expression of FASN protein]; [artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in increased expression of SREBF1 mRNA]; [artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in increased expression of SREBF1 protein]; artenimol inhibits the reaction [Ethanol results in decreased expression of NR1H4 mRNA]; artenimol inhibits the reaction [Ethanol results in decreased expression of NR1H4 protein]; artenimol promotes the reaction [NR1H4 protein inhibits the reaction [Ethanol results in increased activity of GPT protein]]; NR1H4 protein promotes the reaction [artenimol inhibits the reaction [Ethanol results in increased activity of GPT protein]] artenimol results in increased expression of NR1H4 protein Dihydroartemisinin inhibits the reaction [ethanol decreases expression of Nr1h4 mRNA and protein in liver and liver cell nuclei and intestine]
artenimol analog binds to PKM protein PKM protein inhibits the reaction [artenimol results in increased cleavage of CASP3 protein]; PKM protein inhibits the reaction [artenimol results in increased cleavage of GSDME protein]; PKM protein inhibits the reaction [artenimol results in increased expression of IL1B protein]; PKM protein inhibits the reaction [artenimol results in increased secretion of IL18 protein]; PKM protein inhibits the reaction [artenimol results in increased secretion of IL1B protein]
[artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in decreased expression of PPARA mRNA]; [artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in decreased expression of PPARA protein]; artenimol inhibits the reaction [Ethanol results in decreased expression of PPARA mRNA]; artenimol inhibits the reaction [Ethanol results in decreased expression of PPARA protein] Dihydroartemisinin inhibits the reaction [ethanol decreases expression of Ppara mRNA and protein in liver]
artenimol inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of PRKCA protein]; artenimol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of PRKCA protein]
artenimol inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of and results in increased phosphorylation of RELA protein]; artenimol inhibits the reaction [TP53 protein mutant form results in increased phosphorylation of RELA protein]
[artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in increased expression of SREBF1 mRNA]; [artenimol co-treated with NR1H4 protein] inhibits the reaction [Ethanol results in increased expression of SREBF1 protein]; artenimol inhibits the reaction [Ethanol results in increased expression of SREBF1 mRNA]; artenimol inhibits the reaction [Ethanol results in increased expression of SREBF1 protein] Dihydroartemisinin inhibits the reaction [ethanol increases expression of Srebf1 mRNA and protein in liver]
artenimol results in increased phosphorylation of TP53 protein artenimol inhibits the reaction [TP53 protein mutant form results in increased export of Doxorubicin]; artenimol inhibits the reaction [TP53 protein mutant form results in increased phosphorylation of MAPK1 protein]; artenimol inhibits the reaction [TP53 protein mutant form results in increased phosphorylation of MAPK3 protein]; artenimol inhibits the reaction [TP53 protein mutant form results in increased phosphorylation of RELA protein]